Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C Harris

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
The Canadian Journal of Cardiology|April 28, 2016
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, and Assessment of Risk of Pediatric HypertensionKevin C Harris, Geneviève Benoit, Janis Dionne, et al.
The Canadian Journal of Cardiology|April 29, 2017
Hypertension Canada's 2017 Guidelines for the Diagnosis, Assessment, Prevention, and Treatment of Pediatric HypertensionJanis M Dionne, Kevin C Harris, Geneviève Benoit, et al.
Circulation|March 28, 2024
Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory From the American Heart AssociationAnimesh Tandon, Jennifer N Avari Silva, Ami B Bhatt, et al.
Journal of Human Hypertension|May 5, 2022
Variation in paediatric 24-h ambulatory blood pressure monitoring interpretation by Canadian and UK physiciansIsabella Z Stefanova, Manish D Sinha, Douglas J Stewart, et al.
Journal of Human Hypertension|July 11, 2022
Correction to: Variation in paediatric 24-h ambulatory blood pressure monitoring interpretation by Canadian and UK physiciansIsabella Z Stefanova, Manish D Sinha, Douglas J Stewart, et al.
The Canadian Journal of Cardiology|June 6, 2020
Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and BarriersMichael Khoury, Angie Mae Rodday, Andrew S Mackie, et al.
American Heart Journal|May 28, 2019
Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)Liza Miriam Pina, Xiangwen Dong, Liping Zhang, et al.
The Canadian Journal of Cardiology|August 12, 2022
The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice UpdateMichael Khoury, Jean-Luc Bigras, Elizabeth A Cummings, et al.
Paediatrics & Child Health|June 10, 2026
Dyslipidemia in children: diagnosis, evaluation, and managementMichael Khoury, Jean-Luc Bigras, Elizabeth A Cummings, et al.
Pediatric Research|February 15, 2013
Single-ventricle anatomy predicts delayed microstructural brain developmentViyeka Sethi, Sarah Tabbutt, Anastasia Dimitropoulos, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
The Canadian Journal of Cardiology|April 28, 2016
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, and Assessment of Risk of Pediatric HypertensionKevin C Harris, Geneviève Benoit, Janis Dionne, et al.
The Canadian Journal of Cardiology|April 29, 2017
Hypertension Canada's 2017 Guidelines for the Diagnosis, Assessment, Prevention, and Treatment of Pediatric HypertensionJanis M Dionne, Kevin C Harris, Geneviève Benoit, et al.
Circulation|March 28, 2024
Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory From the American Heart AssociationAnimesh Tandon, Jennifer N Avari Silva, Ami B Bhatt, et al.
Journal of Human Hypertension|May 5, 2022
Variation in paediatric 24-h ambulatory blood pressure monitoring interpretation by Canadian and UK physiciansIsabella Z Stefanova, Manish D Sinha, Douglas J Stewart, et al.
Journal of Human Hypertension|July 11, 2022
Correction to: Variation in paediatric 24-h ambulatory blood pressure monitoring interpretation by Canadian and UK physiciansIsabella Z Stefanova, Manish D Sinha, Douglas J Stewart, et al.
The Canadian Journal of Cardiology|June 6, 2020
Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and BarriersMichael Khoury, Angie Mae Rodday, Andrew S Mackie, et al.
American Heart Journal|May 28, 2019
Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study)Liza Miriam Pina, Xiangwen Dong, Liping Zhang, et al.
The Canadian Journal of Cardiology|August 12, 2022
The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice UpdateMichael Khoury, Jean-Luc Bigras, Elizabeth A Cummings, et al.
Paediatrics & Child Health|June 10, 2026
Dyslipidemia in children: diagnosis, evaluation, and managementMichael Khoury, Jean-Luc Bigras, Elizabeth A Cummings, et al.
Pediatric Research|February 15, 2013
Single-ventricle anatomy predicts delayed microstructural brain developmentViyeka Sethi, Sarah Tabbutt, Anastasia Dimitropoulos, et al.
Pageof 10